Citations (80)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (20)
Santiago Palacios & María Jesús Cancelo. (2016) Clinical update on the use of ospemifene in the treatment of severe symptomatic vulvar and vaginal atrophy. International Journal of Women's Health 8, pages 617-626.
Read now
Read now
T. Tzur, D. Yohai & A. Y. Weintraub. (2016) The role of local estrogen therapy in the management of pelvic floor disorders. Climacteric 19:2, pages 162-171.
Read now
Read now
C. Tersigni, N. Di Simone, E. Tempestilli, F. Cianfrini, R. Russo, M. C. Moruzzi, I. D. Amar, A. Fiorelli, G. Scambia & P. Villa. (2015) Non-hormonal treatment of vulvo-vaginal atrophy-related symptoms in post-menopausal women. Journal of Obstetrics and Gynaecology 35:8, pages 835-838.
Read now
Read now
Santiago Palacios & Andrea Mejias. (2015) An update on drugs for the treatment of menopausal symptoms. Expert Opinion on Pharmacotherapy 16:16, pages 2437-2447.
Read now
Read now
S. Palacios, A. Mejía & J. L. Neyro. (2015) Treatment of the genitourinary syndrome of menopause. Climacteric 18:sup1, pages 23-29.
Read now
Read now
Mary Jane Minkin, Ricardo Maamari & Suzanne Reiter. (2014) Postmenopausal vaginal atrophy: evaluation of treatment with local estrogen therapy. International Journal of Women's Health 6, pages 281-288.
Read now
Read now
Gregory T Wurz, Chiao-Jung Kao & Michael W DeGregorio. (2014) Safety and efficacy of ospemifene for the treatment of dyspareunia associated with vulvar and vaginal atrophy due to menopause. Clinical Interventions in Aging 9, pages 1939-1950.
Read now
Read now
Renata Schvartzman, Adriane Bertotto, Luiza Schvartzman & Maria Celeste Osório Wender. (2014) Pelvic Floor Muscle Activity, Quality of Life, and Sexual Function in Peri- and Recently Postmenopausal Women With and Without Dyspareunia: A Cross-Sectional Study. Journal of Sex & Marital Therapy 40:5, pages 367-378.
Read now
Read now
S. R. Goldstein, G. A. Bachmann, P. R. Koninckx, V. H. Lin, D. J. Portman & O. Ylikorkala. (2014) Ospemifene 12-month safety and efficacy in postmenopausal women with vulvar and vaginal atrophy. Climacteric 17:2, pages 173-182.
Read now
Read now
Jill M Krapf, Zoe R Belkin & Andrew T Goldstein. (2013) Advances in the treatment of vulvovaginal atrophy. Expert Review of Obstetrics & Gynecology 8:5, pages 457-465.
Read now
Read now
U. Jaisamrarn, S. Triratanachat, S. Chaikittisilpa, P. Grob, V. Prasauskas & N. Taechakraichana. (2013) Ultra-low-dose estriol and lactobacilli in the local treatment of postmenopausal vaginal atrophy. Climacteric 16:3, pages 347-355.
Read now
Read now
A. Sinha & A. A. A. Ewies. (2013) Non-hormonal topical treatment of vulvovaginal atrophy: an up-to-date overview. Climacteric 16:3, pages 305-312.
Read now
Read now
O. K. Duffy, L. Iversen & P. C. Hannaford. (2013) Factors associated with reporting classic menopausal symptoms differ. Climacteric 16:2, pages 240-251.
Read now
Read now
Luciano Mariani, Angiolo Gadducci, Enrico Vizza, Silverio Tomao & Patrizia Vici. (2013) Vaginal atrophy in breast cancer survivors: role of vaginal estrogen therapy. Gynecological Endocrinology 29:1, pages 25-29.
Read now
Read now
Lian Ulrich. (2012) The role of local vaginal estrogen treatment in urogenital atrophy. Expert Review of Obstetrics & Gynecology 7:6, pages 545-556.
Read now
Read now
D. W. Sturdee & N. Panay. (2010) Recommendations for the management of postmenopausal vaginal atrophy. Climacteric 13:6, pages 509-522.
Read now
Read now
Isabel Santos & Steve Clissold. (2010) Urogenital disorders associated with oestrogen deficiency: the role of promestriene as topical oestrogen therapy. Gynecological Endocrinology 26:9, pages 644-651.
Read now
Read now
Jamie L McCall & Michael W DeGregorio. (2010) Pharmacologic evaluation of ospemifene. Expert Opinion on Drug Metabolism & Toxicology 6:6, pages 773-779.
Read now
Read now
Vivian Lewis. (2009) Undertreatment of menopausal symptoms and novel options for comprehensive management. Current Medical Research and Opinion 25:11, pages 2689-2698.
Read now
Read now
R. E. Nappi, F. Albani, L. Chiovato & F. Polatti. (2009) Local estrogens for quality of life and sexuality in postmenopausal women with cardiovascular disease. Climacteric 12:sup1, pages 112-116.
Read now
Read now
Articles from other publishers (60)
Ishrat Hussain & Vikram Sinai Talaulikar. (2023) A systematic review of randomised clinical trials – The safety of vaginal hormones and selective estrogen receptor modulators for the treatment of genitourinary menopausal symptoms in breast cancer survivors. Post Reproductive Health 29:4, pages 222-231.
Crossref
Crossref
Katarzyna Tomczyk, Karolina Chmaj-Wierzchowska, Katarzyna Wszołek & Maciej Wilczak. (2023) New Possibilities for Hormonal Vaginal Treatment in Menopausal Women. Journal of Clinical Medicine 12:14, pages 4740.
Crossref
Crossref
Ahmed Abdelgader, Mershen Govender, Pradeep Kumar & Yahya E. Choonara. (2023) Intravaginal Drug Delivery Systems to Treat the Genitourinary Syndrome of Menopause: Towards the Design of Safe and Efficacious Estrogen-loaded Prototypes. Journal of Pharmaceutical Sciences 112:6, pages 1566-1585.
Crossref
Crossref
Maimaiti Tuniyazi & Naisheng Zhang. (2023) Possible Therapeutic Mechanisms and Future Perspectives of Vaginal Microbiota Transplantation. Microorganisms 11:6, pages 1427.
Crossref
Crossref
Kanchi Ravi Don, Kanchi Ravi Padma, Baddula Venkata Sai Chandana, Mohammad Reshma Anjum & Sankari Mohan. (2023) Influence of Vaginal Microbiota on Sexual and Reproductive Health: A Mini Review. Entomology and Applied Science Letters 10:1, pages 11-28.
Crossref
Crossref
Daniel María Lubián López. (2022) Management of genitourinary syndrome of menopause in breast cancer survivors: An update. World Journal of Clinical Oncology 13:2, pages 71-100.
Crossref
Crossref
Jill Krapf, Ann Nwabuebo & Lucia Miller. 2022. Each Woman’s Menopause: An Evidence Based Resource. Each Woman’s Menopause: An Evidence Based Resource
257
282
.
Paula Punzón-Jiménez & Elena Labarta. (2021) The impact of the female genital tract microbiome in women health and reproduction: a review. Journal of Assisted Reproduction and Genetics 38:10, pages 2519-2541.
Crossref
Crossref
Paula Briggs & Dharani K Hapangama. (2021) Urogenital atrophy: The ‘unknown factors’ challenging current practice. Post Reproductive Health 27:2, pages 109-120.
Crossref
Crossref
I-Hsuan Yang, I-En Lin, Tzu-Chien Chen, Zhi-Yu Chen, Che-Yung Kuan, Jhih-Ni Lin, Yu-Chia Chou & Feng-Huei Lin. (2021) Synthesis, characterization, and evaluation of BDDE crosslinked chitosan-TGA hydrogel encapsulated with genistein for vaginal atrophy. Carbohydrate Polymers 260, pages 117832.
Crossref
Crossref
Suhyun ShimKyung-Min ParkYoun-Jee ChungMee-Ran Kim. (2021) Updates on Therapeutic Alternatives for Genitourinary Syndrome of Menopause: Hormonal and Non-Hormonal Managements. Journal of Menopausal Medicine 27:1, pages 1.
Crossref
Crossref
E. V. Tikhomirova, V. E. Balan & O. S. Fomina-Nilova. (2020) Current treatment options for genitourinary syndrome. Meditsinskiy sovet = Medical Council:13, pages 91-96.
Crossref
Crossref
R.T. Pavlović, S.M. Janković, J.R. Milovanović, S.M. Stefanović, M.M. Folić, O.Z. Milovanović, C. Mamillapalli & M.N. Milosavljević. (2019) The Safety of Local Hormonal Treatment for Vulvovaginal Atrophy in Women With Estrogen Receptor-positive Breast Cancer Who Are on Adjuvant Aromatase Inhibitor Therapy: Meta-analysis. Clinical Breast Cancer 19:6, pages e731-e740.
Crossref
Crossref
Gerardo Leyva-Gómez, María L. Del Prado-Audelo, Silvestre Ortega-Peña, Néstor Mendoza-Muñoz, Zaida Urbán-Morlán, Maykel González-Torres, Manuel González-Del Carmen, Gabriela Figueroa-González, Octavio D. Reyes-Hernández & Hernán Cortés. (2019) Modifications in Vaginal Microbiota and Their Influence on Drug Release: Challenges and Opportunities. Pharmaceutics 11:5, pages 217.
Crossref
Crossref
Nur Amanina Syariff Tan, Nelli Giribabu, Kamarulzaman Karim, Shaik Nyamathulla & Naguib Salleh. (2019) Intravaginal treatment with Marantodes pumilum (Kacip Fatimah) ameliorates vaginal atrophy in rats with post-menopausal condition. Journal of Ethnopharmacology 236, pages 9-20.
Crossref
Crossref
Ellen Wejde, Ann Nozohoor Ekmark & Pernilla Stenström. (2018) Treatment with oestrogen or manual separation for labial adhesions – initial outcome and long-term follow-up. BMC Pediatrics 18:1.
Crossref
Crossref
Fernand Labrie, David F. Archer, William Koltun, Andrée Vachon, Douglas Young, Louise Frenette, David Portman, Marlene Montesino, Isabelle Côté, Julie Parent, Lyne Lavoie, Adam Beauregard BSc, Céline Martel, Mario Vaillancourt, John Balser & Érick Moyneur. (2018) Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause. Menopause 25:11, pages 1339-1353.
Crossref
Crossref
Joan Pitkin. (2018) BMS – Consensus statement. Post Reproductive Health 24:3, pages 133-138.
Crossref
Crossref
A. Stuursma, C.M.G. van Driel, N.J. Wessels, G.H. de Bock & M.J.E. Mourits. (2018) Severity and duration of menopausal symptoms after risk-reducing salpingo-oophorectomy. Maturitas 111, pages 69-76.
Crossref
Crossref
Masumeh Ghazanfarpour, Paymaneh Shokrollahi, Talat Khadivzadeh, Nosrat Baharian Sharghi, Khadijeh Mirzaii Najmabadi, Masoudeh Babakhanian & Amir Hossine Jafarian. (2017) Effect of Foeniculum vulgare (fennel) on vaginal atrophy in postmenopausal women: A double-blind, randomized, placebo-controlled trial. Post Reproductive Health 23:4, pages 171-176.
Crossref
Crossref
Željka Vanić & Nataša Škalko-Basnet. 2017. Functional Hydrogels in Drug Delivery. Functional Hydrogels in Drug Delivery
259
302
.
Meena Dayal & Preeti Yadav. (2017) Management of Postmenopausal Vaginal Atrophy: Review of Literature. Journal of SAFOMS 5:1, pages 51-57.
Crossref
Crossref
Alina Weissmann-Brenner, Tuvia Bayevsky & Israel Yoles. (2017) Compliance to vaginal treatment—tablets versus cream: a retrospective 9 years study. Menopause 24:1, pages 73-76.
Crossref
Crossref
Eve Overton, Erin Hofstatter, Devin Miller & Elena Ratner. 2017. Essentials of Menopause Management. Essentials of Menopause Management
303
322
.
Tatiane Fernandes, Lucia Helena Costa-Paiva, Adriana Orcesi Pedro, Luiz Francisco Cintra Baccaro & Aarão Mendes Pinto-Neto. (2016) Efficacy of vaginally applied estrogen, testosterone, or polyacrylic acid on vaginal atrophy: a randomized controlled trial. Menopause 23:7, pages 792-798.
Crossref
Crossref
Bilal Chughtai, James C Forde, Jessica Buck, Tirsit Asfaw, Richard Lee, Alexis E Te & Steven A Kaplan. (2016) The concomitant use of fesoterodine and topical vaginal estrogen in the management of overactive bladder and sexual dysfunction in postmenopausal women. Post Reproductive Health 22:1, pages 34-40.
Crossref
Crossref
Fernand Labrie, David F. Archer, William Koltun, Andrée Vachon, Douglas Young, Louise Frenette, David Portman, Marlene Montesino, Isabelle Côté, Julie Parent, Lyne Lavoie, Adam Beauregard, Céline Martel, Mario Vaillancourt, John Balser & Érick Moyneur. (2016) Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause. Menopause 23:3, pages 243-256.
Crossref
Crossref
Martha Hickey, Jennifer L. Marino & Gilda Tachedjian. (2016) Critical Review. JAIDS Journal of Acquired Immune Deficiency Syndromes 71:1, pages 1-7.
Crossref
Crossref
Salvatore Caruso, Stefano Cianci, Francesca F. Amore, Betty Ventura, Elisa Bambili, Saveria Spadola & Antonio Cianci. (2016) Quality of life and sexual function of naturally postmenopausal women on an ultralow-concentration estriol vaginal gel. Menopause 23:1, pages 47-54.
Crossref
Crossref
Kandace P. McGuire. 2016. Breast Disease. Breast Disease
375
387
.
David Portman, Lee Shulman, Jason Yeaw, Sha Zeng, Chioma Uzoigwe, Ricardo Maamari & Neeraj N. Iyer. (2015) One-year treatment persistence with local estrogen therapy in postmenopausal women diagnosed as having vaginal atrophy. Menopause 22:11, pages 1197-1203.
Crossref
Crossref
Priscila Goncalves & Hunter Groninger. (2015) Sexual Dysfunction in Cancer Patients and Survivors #293. Journal of Palliative Medicine 18:8, pages 714-715.
Crossref
Crossref
J. Sassarini & M. A. Lumsden. (2015) Oestrogen replacement in postmenopausal women. Age and Ageing 44:4, pages 551-558.
Crossref
Crossref
Zoe Ostle. (2015) Vaginal oestrogen for overactive bladder in post-menopausal women. British Journal of Nursing 24:11, pages 582-585.
Crossref
Crossref
V. E. Balan, Zh. S. Amirova, L. A. Kovaleva, I. V. Krasnopolskaya & E. I. Ermakova. (2015) Specific features of therapy for disordered urination in menopausal women. Rossiiskii vestnik akushera-ginekologa 15:3, pages 29.
Crossref
Crossref
M. A. Weber, J. Limpens & J. P. W. R. Roovers. (2014) Assessment of vaginal atrophy: a review. International Urogynecology Journal 26:1, pages 15-28.
Crossref
Crossref
Jill M. Krapf, Zoe Belkin, Frank Dreher & Andrew T. Goldstein. 2015. Skin, Mucosa and Menopause. Skin, Mucosa and Menopause
229
235
.
Ryan Sobel & Jack D. Sobel. 2015. Skin, Mucosa and Menopause. Skin, Mucosa and Menopause
175
180
.
Aysun Karabulut, Sahika Pınar Akyer, Gülcin Abban Mete & Barbaros Sahin. (2014) Effects of menopause, diabetes mellitus and steroid use on type I mesh-induced tissue reaction in a rat model. European Journal of Obstetrics & Gynecology and Reproductive Biology 179, pages 27-31.
Crossref
Crossref
David Sturdee. (2014) Urogenital atrophy. Post Reproductive Health 20:2, pages 73-75.
Crossref
Crossref
D. Portman, S. Palacios, R.E. Nappi & A.O. Mueck. (2014) Ospemifene, a non-oestrogen selective oestrogen receptor modulator for the treatment of vaginal dryness associated with postmenopausal vulvar and vaginal atrophy: A randomised, placebo-controlled, phase III trial. Maturitas 78:2, pages 91-98.
Crossref
Crossref
Gilbert Donders, Patrick Neven, Maximilian Moegele, Anneleen Lintermans, Gert Bellen, Valdas Prasauskas, Philipp Grob, Olaf Ortmann & Stefan Buchholz. (2014) Ultra-low-dose estriol and Lactobacillus acidophilus vaginal tablets (Gynoflor®) for vaginal atrophy in postmenopausal breast cancer patients on aromatase inhibitors: pharmacokinetic, safety, and efficacy phase I clinical study. Breast Cancer Research and Treatment 145:2, pages 371-379.
Crossref
Crossref
JoAnn V. Pinkerton & Frank Z. Stanczyk. (2014) Clinical effects of selective estrogen receptor modulators on vulvar and vaginal atrophy. Menopause 21:3, pages 309-319.
Crossref
Crossref
Yuanshan Cui, Huantao Zong, Huilei Yan, Nan Li & Yong Zhang. (2014) The Efficacy and Safety of Ospemifene in Treating Dyspareunia Associated with Postmenopausal Vulvar and Vaginal Atrophy: A Systematic Review and Meta‐Analysis. The Journal of Sexual Medicine 11:2, pages 487-497.
Crossref
Crossref
Christine Bradway & Joseph Boullata. (2014) Pharmacologic therapy for female sexual dysfunction. The Nurse Practitioner 39:1, pages 16-27.
Crossref
Crossref
Sukanya JAROENPORN, Nontakorn URASOPON, Gen WATANABE & Suchinda MALAIVIJITNOND. (2014) Improvements of Vaginal Atrophy without Systemic Side Effects after Topical Application of Pueraria mirifica, a Phytoestrogen-rich Herb, in Postmenopausal Cynomolgus Macaques. Journal of Reproduction and Development 60:3, pages 238-245.
Crossref
Crossref
Lino Del Pup, Raffaele Di Francia, Carla Cavaliere, Gaetano Facchini, Giorgio Giorda, Paolo De Paoli & Massimiliano Berretta. (2013) Promestriene, a specific topic estrogen. Review of 40 years of vaginal atrophy treatment. Anti-Cancer Drugs 24:10, pages 989-998.
Crossref
Crossref
Sarah L. Berga. (2013) Profile of Ospemifene in the Breast. Reproductive Sciences 20:10, pages 1130-1136.
Crossref
Crossref
Surveen Ghumman. (2013) Atrophic Vaginitis: Diagnosis and Treatment. Journal of SAFOMS 1:1, pages 4-12.
Crossref
Crossref
David J. Portman, Gloria A. Bachmann & James A. Simon. (2013) Ospemifene, a novel selective estrogen receptor modulator for treating dyspareunia associated with postmenopausal vulvar and vaginal atrophy. Menopause 20:6, pages 623-630.
Crossref
Crossref
H. Loertzer & P. Schneider. (2013) Belastungsinkontinenz der Frau im AlterStress incontinence in elderly women. Der Urologe 52:6, pages 813-820.
Crossref
Crossref
James A. Simon, Vivian H. Lin, Cathy Radovich & Gloria A. Bachmann. (2013) One-year long-term safety extension study of ospemifene for the treatment of vulvar and vaginal atrophy in postmenopausal women with a uterus. Menopause 20:4, pages 418-427.
Crossref
Crossref
Vijayashree Murthy & Ronald S. Chamberlain. (2017) Menopausal Symptoms in Young Survivors of Breast Cancer: A Growing Problem without an Ideal Solution. Cancer Control 19:4, pages 317-329.
Crossref
Crossref
Santiago Palacios, M. Jesús Cancelo, Camil Castelo-Branco, Silvia González & Miguel Ángel Olalla. (2012) Recomendaciones de la Sociedad Española de Ginecología y Obstetricia sobre la prevención y el tratamiento de la atrofia vaginal. Progresos de Obstetricia y Ginecología 55:8, pages 408-415.
Crossref
Crossref
Adam Ostrzenski. (2012) Vaginal Rugation Rejuvenation (Restoration): A New Surgical Technique for an Acquired Sensation of Wide/Smooth Vagina. Gynecologic and Obstetric Investigation 73:1, pages 48-52.
Crossref
Crossref
Orkun Tan, Karen Bradshaw & Bruce R. Carr. (2012) Management of vulvovaginal atrophy-related sexual dysfunction in postmenopausal women. Menopause 19:1, pages 109-117.
Crossref
Crossref
Michael L. Krychman. (2011) Vaginal Estrogens for the Treatment of Dyspareunia. The Journal of Sexual Medicine 8:3, pages 666-674.
Crossref
Crossref
Chitra Raghunandan, Swati Agrawal, Priyanka Dubey, Monisha Choudhury & Anju Jain. (2010) Original Research—Endocrinology: A Comparative Study of the Effects of Local Estrogen With or Without Local Testosterone on Vulvovaginal and Sexual Dysfunction in Postmenopausal Women. The Journal of Sexual Medicine 7:3, pages 1284-1290.
Crossref
Crossref
Catherine Lynch. (2009) Vaginal Estrogen Therapy for the Treatment of Atrophic Vaginitis. Journal of Women's Health 18:10, pages 1595-1606.
Crossref
Crossref
Amnon Brzezinski & Abraham Benshushan. (2009) Estrogen for vulvovaginal symptoms. Menopause 16:5, pages 848-850.
Crossref
Crossref